In the complaint, Factor alleges that Cellectis transformed its research program after learning about Factor's patented mRNA TALENs technology in 2013 and proceeded to illegally exploit that ...
HSINCHU, Sept. 24, 2025 /PRNewswire/ -- M31 Technology Corporation (M31), a leading silicon intellectual property (IP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback